Neurogene (NGNE) Accumulated Depreciation & Amortization (2018 - 2025)
Neurogene (NGNE) has disclosed Accumulated Depreciation & Amortization for 4 consecutive years, with $2.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Accumulated Depreciation & Amortization fell 5.93% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2025, down 5.93%, and an annual FY2024 reading of $3.2 million, changed N/A over the prior year.
- Accumulated Depreciation & Amortization was $2.3 million for Q3 2025 at Neurogene, up from $1.5 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $3.2 million in Q4 2024 and bottomed at $749000.0 in Q1 2025.